2Q15 2Q14 % Change Million EUR HY15 HY14 % Change

Size: px

Start display at page:

Download "2Q15 2Q14 % Change Million EUR HY15 HY14 % Change"

Robyn Bell
5 years ago
Views:

4 2Q15 2Q14 % Change Million EUR HY15 HY14 % Change % Revenue Group % Revenue Other segment % Revenue at comparable scope % % Rebitda Group % Rebitda Other segment % Rebitda at comparable scope % Rebit Group % - Rebit Other segment Rebit at comparable scope % Profit (+) / loss (-) for the period % Total comprehensive income for the period Cash flow from operating activities minus capital expenditure % % Net debt Notional net debt

7 102.8mEUR Industrial solutions 26.9% Agro meur 43.9% 85.0% Agro 29.3% Biovalorization 22.3% Industrial solutions 0.0% -7.3% Bio-valorization

8 AGRO Million EUR HY15 HY14 % change Revenue % REBITDA % REBITDA margin 23.5% 20.3% - REBIT % REBIT margin 20.7% 17.6% -

9 BIO-VALORIZATION Million EUR HY15 HY14 % change Revenue % REBITDA nm REBITDA margin -3.0% 2.7% - REBIT nm REBIT margin -8.7% -3.2% -

10 INDUSTRIAL SOLUTIONS Million EUR HY15 HY14 % change Revenue % REBITDA % REBITDA margin 10.0% 8.0% - REBIT % REBIT margin 4.9% 3.2% -

11 REBIT HY15 Non-recurring items EBIT Net finance costs Income Tax Expense Share of result of investments PROFIT HY15 (20.0) 6.0 (14.5) (6.7) 40.4

12 Million EUR ASSETS Total non-current assets Property, plant and equipment Goodwill Other intangible assets Investments accounted for using the equity method Other investments Deferred tax assets Trade and other receivables Derivative financial instruments Total current assets Inventories Trade and other receivables Derivative financial instruments Cash and cash equivalents Non-current assets classified as held for sale Total assets 1, ,185.4

13 Million EUR EQUITY AND LIABILITIES Total equity Equity attributable to equity holders of the company Issued capital Share premium Reserves and retained earnings Non-controlling interest Total liabilities Total non-current liabilities Loans and borrowings Employee benefits Provisions Trade and other payables Derivative financial instruments Deferred tax liabilities Total current liabilities Bank overdrafts Loans and borrowings Trade and other payables Derivative financial instruments Current tax liabilities Employee benefits Provisions Total equity and liabilities 1, ,185.4

14 Million EUR OPERATING ACTIVITIES Profit (+) / loss (-) for the period Depreciation, amortization and impairment losses on tangible assets, goodwill and other intangible assets Impairment losses on disposal groups Changes in provisions Finance costs/(income) - net Loss / (profit) on sale of non-current assets Share of result of equity accounted investees, net of income tax Income tax expense Other non-cash items Changes in inventories Changes in trade and other receivables Changes in trade and other payables Cash generated from operations Income tax (paid)/received Dividends received Dividends received from other investments Cash flow from operating activities

15 Million EUR INVESTING ACTIVITIES Acquisition of property, plant and equipment Acquisition of other intangible assets Acquisition of businesses, net of cash acquired Proceeds from the sale of property, plant and equipment Proceeds from the sale of subsidiaries, net of cash disposed of Proceeds from the sale of other investments Capital decrease from investments accounted for using the equity method Cash flow from investing activities FINANCING ACTIVITIES Capital increase from non-controlling interests Change in non-recourse factoring and securitization Proceeds from new borrowings (Reimbursement) of borrowings Cash movement resulting from settlement financial instruments Interest paid Interest received Other finance costs paid Decrease of long term receivables Cash flow from financing activities Net increase / (decrease) in cash and cash equivalents Effect of exchange rate differences Cash and cash equivalents less bank overdrafts at the beginning of the period Cash and cash equivalents less bank overdrafts at the end of the period

17 Tessenderlo Group is a worldwide specialty company, focused on food, agriculture, water management and on valorizing bio-residuals. The group employs about 4,800 people and is a leader in most of its markets, with a consolidated revenue of 1.4 billion EUR in Tessenderlo Chemie NV is listed on NYSE Eurolist by Euronext Brussels and is part of Next 150 and BEL Mid indices. Financial News wires: Bloomberg: TESB BB Reuters: TesBt.BR Datastream: B:Tes HY15 Results August 26, 2015

4Q15 4Q14 % Change Million EUR 12M15 12M14 % Change

4Q15 4Q14 % Change Million EUR 12M15 12M14 % Change 374.4 319.8 17.1% Revenue Group 1,589.0 1,434.2 10.8% - -1.7 - Revenue Other segment - -34.7 374.4 318.1 17.7% Revenue at comparable scope 1,589.0 1,399.5